Treatment

IgG4ward! Fireside Chat: EULAR 2026 Research Update – New insights into IgG4-related disease (IgG4-RD)

In this IgG4ward! Fireside Chat, Dr. John H. Stone and Dr. Emmanuel Della-Torre discuss key research highlights presented at the 2026 EULAR Congress. The webinar explores new findings from the MITIGATE and INDIGO clinical trials, emerging insights into disease flares, and what these advances may mean for the future of IgG4-related disease care.

PeachJAM Video Series: How Do I Know if My IgG4-RD Is Active?

IgG4ward! PeachJAM Series: Avoiding Side Effects in IgG4-related Disease (IgG4-RD)

IgG4ward! PeachJAM Series: Applying Clinical Trial Results to Practice – How Should IgG4-RD Be Treated Now & in 2026?

Vaccines & IgG4-RD: Expert Guidance from Our Fireside Chat

Hear Why We’re Talking About Vaccines — An IgG4-RD Patient Story

IgG4-RD and Treatment | Fireside Chat Recap + Downloadable Guide

Hope Is Here: A Breakthrough Moment for the IgG4-RD Community

IgG4ward! Jam Video Series- Video 7 - Managing IgG4-RD Treatment Side Effects: Avoiding the Side-Effects of Treatment, Steroids, B-Cell Depletion & Vaccines with Dr. John H. Stone

IgG4ward! Jam Video Series- Video 6 -Understanding the Extent of the Disease and Monitoring Over Time for Relapse with Dr. Mollie Carruthers

IgG4ward! Good Question Series: Staying Protected Against Respiratory Viruses—What Vaccines Do I Need?

IgG4ward! Good Question Series: Can a Patient Be Treated Without an Official Diagnosis?

“I have enlarged lacrimal glands. A biopsy was done on a lesion from one of the glands showing IgG:IgG4 ratio ~100% and 236 IgG4 blood level. I haven’t been officially diagnosed with IgG4-RD. What can happen if I refuse the prednisone?”

Question of the Week: Will the risk of PjP infections be higher or lower compared with prednisone of patients with IgG4-RD who are treated with B cell depletion?

IgG4-RD Question of the Week: Were “Comfort Measures Only” Appropriate?

Question of the Week: “Should I continue on prednisone or should I switch to another treatment – for example, B cell depletion?”

Question of the Week: “It’s been more than a year since my last rituximab infusion and my CD20 count is back in the normal range. Why do I not have any signs of an IgG4-RD flare?”

IgG4ward! Question of the Week: “How is the effectiveness of B cell depletion determined after the treatment is administered?”